Jaguar Health, Inc. (NASDAQ:JAGX)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $0.13, but opened at $0.14. Jaguar Health shares last traded at $0.15, with a volume of 6628 shares traded.
Separately, ValuEngine upgraded Jaguar Health from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.
The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.91 and a current ratio of 1.16.
About Jaguar Health
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.